Showing results (351-360 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|November 11, 2024
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, et al.
Liver Cancer|August 8, 2024
A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM TrialZhi-Mei Huang, Xue Han, Jian Wang, et al.
Liver Cancer|August 8, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide StudyGi-Ae Kim, Seogsong Jeong, Heejoon Jang, et al.
Liver Cancer|August 8, 2024
Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 StudyMasatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, et al.
Liver Cancer|August 8, 2024
Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)Xiufeng Liu, Yinying Lu, Weiping Zhou, et al.
Liver Cancer|October 30, 2023
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 TrialPhilippe Merle, Masatoshi Kudo, Julien Edeline, et al.
Liver Cancer|August 18, 2023
Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 InhibitorZhuo Cheng, Tianmei Zeng, Guang Yang, et al.
Liver Cancer|December 7, 2023
Real-Time Fluorescence Imaging to Identify Cholangiocarcinoma in the Extrahepatic Biliary Tree Using an Enzyme-Activatable ProbeRyugen Takahashi, Takeaki Ishizawa, Yoshinori Inagaki, et al.
Liver Cancer|December 7, 2023
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment ModalityAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Liver Cancer|December 7, 2023
Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor LocationKazuo Asano, Ken Kageyama, Akira Yamamoto, et al.
Pageof 55